{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05528653",
            "orgStudyIdInfo": {
                "id": "IN-US-412-6419"
            },
            "organization": {
                "fullName": "Vivent Health",
                "class": "OTHER"
            },
            "briefTitle": "Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: \"e-PrEP\"",
            "officialTitle": "Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: \"e-PrEP\"",
            "acronym": "e-PrEP",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "telehealth-as-a-modality-to-increase-the-uptake-of-prep-services-in-black-and-latino-e-prep"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-07-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-19",
            "studyFirstSubmitQcDate": "2022-08-31",
            "studyFirstPostDateStruct": {
                "date": "2022-09-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Cindy Firnhaber",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Vivent Health"
            },
            "leadSponsor": {
                "name": "Vivent Health",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Gilead Sciences",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)",
            "detailedDescription": "The goal of this study is to determine whether incorporating a telehealth model that allows for same-day appointments for PrEP delivery with the support of navigation leads to increased uptake and persistence of PrEP in young MSM/transgender of color and individuals in rural communities that have disproportionately not used PrEP. The investigators will accomplish this by using an effectiveness-hybrid design that will allow us to both evaluate the interventions impact on relevant clinical outcomes as well as the effectiveness of the implementation strategy. Our hypothesis is that by removing some of the barriers to care such as transportation, childcare, work schedule and potentially stigma with repeated clinic visits, the investigators will increase the uptake and persistence of PrEP amongst communities who historically have had many barriers to care and have not started PrEP."
        },
        "conditionsModule": {
            "conditions": [
                "HIV Prevention"
            ],
            "keywords": [
                "HIV"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Open Label Descovy",
                    "type": "OTHER",
                    "description": "Descovy for PrEP",
                    "interventionNames": [
                        "Drug: Descovy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Descovy",
                    "description": "HIV infection pre-exposure prophylaxis",
                    "armGroupLabels": [
                        "Open Label Descovy"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": ": To increase the number and proportion of individuals who start PrEP who have been under-represented in PrEP uptake including those who identify as Black and/or Latino MSM.",
                    "description": "Offer PrEP care via tele-health to reduce obstacles that clients have in coming to clinic.",
                    "timeFrame": "18 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To increase the number and proportion of individuals who are still taking PrEP and engaged in care at the end of 6 months by 30% and remain HIV negative including those who identify as Black and/or Latino MSM.",
                    "description": "Facilitate maintenance of care by offering Tele-health for initial and ongoing PrEP care to reduce social and structural barriers.",
                    "timeFrame": "18 months"
                },
                {
                    "measure": "To assess the acceptability and implementation of the intervention by both patients and clinic staff.",
                    "description": "Obtain quantitative feedback via survey about services provided via Telehealth from patients and clinic staff.",
                    "timeFrame": "18 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 years and older\n2. No medical or mental health comorbidity that would preclude participating in a clinical study as deemed by the study investigator\n3. Able to understand and sign consent in English or with other language interpreter\n4. Able to stay in the state catchment area of the license health care provider\n5. No use of PrEP for more than 30 days in the last year\n\nExclusion Criteria:\n\n1. HIV positive\n2. If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) \\<30 mg/g\n3. \\<18 years of age\n4. No access to Internet or devise for telehealth\n5. Cis-gender Women",
            "healthyVolunteers": true,
            "sex": "MALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Billie Thomas",
                    "role": "CONTACT",
                    "phone": "720-782-5003",
                    "email": "billie.thomas@viventhealth.org"
                },
                {
                    "name": "Alexis Moore, MPH",
                    "role": "CONTACT",
                    "phone": "303-393-8050",
                    "email": "alexis.moore@viventhealth.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Cindy Firnhaber, MD",
                    "affiliation": "Vivent Health",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Vivent Health",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80245",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Vivent Health",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Cockerham, MD",
                            "role": "CONTACT",
                            "email": "leslie.cockerham@viventhealth.org"
                        },
                        {
                            "name": "Sarah Chandler",
                            "role": "CONTACT",
                            "email": "sarah.chandler@Viventhealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Viventh Health",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000613801",
                    "term": "Emtricitabine tenofovir alafenamide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000018894",
                    "term": "Reverse Transcriptase Inhibitors"
                },
                {
                    "id": "D000019384",
                    "term": "Nucleic Acid Synthesis Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000019380",
                    "term": "Anti-HIV Agents"
                },
                {
                    "id": "D000044966",
                    "term": "Anti-Retroviral Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M343325",
                    "name": "Emtricitabine tenofovir alafenamide",
                    "asFound": "Transoral",
                    "relevance": "HIGH"
                },
                {
                    "id": "M296",
                    "name": "Tenofovir",
                    "relevance": "LOW"
                },
                {
                    "id": "M294",
                    "name": "Emtricitabine",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20935",
                    "name": "Reverse Transcriptase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M21350",
                    "name": "Anti-HIV Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M25428",
                    "name": "Anti-Retroviral Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}